Abstract
To obtain a bifunctional protein simultaneously showing bioactivity of anticoagulant and fibrinolytic for use in the treatment of thrombotic diseases, we constructed a fusion protein (HV12p–rPA) containing C-terminal 12-residue of hirudin-PA (HV12p) and reteplase (rPA). The fusion protein, in which HV12p was linked to rPA via Gly–Gly–Gly, was successfully expressed in an inactive form of inclusion bodies in Escherichia coli. HV12p–rPA was identified by sodium dodecylsulfate-polyacrylamide gel electrophoresis. The expression level of HV12p–rPA was optimized by an orthogonal method and finally enhanced from 12 % to approximate 30 %. We also deeply investigated the condition of renaturation of HV12p–rPA, and the inactive protein was partly renatured through various conditions. The refolding efficacy of HV12p–rPA estimated by the recovery of fibrinolytic activity varied from 0.03 % to 16.6 % and the anticoagulant activity fluctuated in the range from 41 to 2,297 ATU/mg. Bioassays indicated that the resulted fusion protein, as expected, exhibited both fibrinolytic and anticoagulant activities. These works laid a foundation for further characterization of HV12p–rPA.
Similar content being viewed by others
Abbreviations
- DBA:
-
Diaminobenzidine
- GSSG:
-
Oxidized glutathione
- GSH:
-
Reduced glutathione
- HRP:
-
Horse radish peroxidase
- HV12p:
-
C-terminal 12-residue of hirudin-PA
- rPA:
-
Reteplase
- HV12p–rPA:
-
HV12p–Gly–Gly–Gly–rPA
- IPTG:
-
Isopropyl thiogalactoside
- PCR:
-
Polymerase chain reaction
- PVDF:
-
Polyvinylidene fluoride
- SDS-PAGE:
-
Sodium dodecylsulfate-polyacrylamide gel electrophoresis
- SEC:
-
Size-exclusion chromatography
- t-PA:
-
Tissue-type plasminogen activator
References
Bennion BJ, Daggett V (2003) PNAS 100:5142–5147
Chang JY, Ngai PK, Rink H, Dennis S, Schlaeppi JM (1990) FEBS Lett 261:287–290
Del Zoppo GJ, Saver JL, Jauch EC, Adams HP (2009) Stroke 40:2945–2948
Dodt J, Seemuller U, Fritz H, Fink E (1988) US Patent:4767742 Plantorgan-Werk Heinrich G. F. Christensen, KG
Dohi T, Daida H (2010) Nippon Rinsho 68:592–596
Ewenstein BM (1997) N Engl J Med 337:1383–1384
Feng CG, Chen M, Qi S, Song XR (2004) Chin Phar J 40:385–388
Feng X (2001) Prog Biochem Biophys 28:482–485
Ferrell M, Fuster V, Becker RC (1994) Springer US 60:1–13
Fritz M (1994) Thromb Res 74:1–23
Fritz M, Gertrude E, Perlmann LL (1970) Academic Press, vol 19, pp 924–932
Hevehan DL, De Bernardez Clark E (1997) Biotechnol Bioeng 54:221–230
HLilie H, Schwarz E, Rudolph R (1998) Curr Opin Biotechnol 9:497–501
Investigators TG (1993) N Engl J Med 329:673–682
Jang IK, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, Ma JW, Collen D (1989) Circulation 79:920–928
Lansberg MG, Bluhmki E, Thijs VN (2009) Stroke 40:2438–2441
Lazar JB, Winant RC, Johnson PH (1991) J Biol Chem 266:685–688
Loison G, Findeli A, Bernard S, Nguyen-Juilleret M, Marquet M, Riehl-Bellon N, Carvallo D, Guerra-Santos L, Brown SW, Courtney M, Roitsch C, Lemoine Y (1988) Nat Biotech 6:72–77
Markwardt F (1991) Thromb Haemost 66:141–152
Marler JR, GROUP (1995) N Engl J Med 333:1581–1587
Martin U, Dörge L, Fischer S (1996) Br J Pharmacol 118:271–276
Martin U, Sponer G, Strein K (1992) J Am Coll Cardiol 19:433–440
Menssen HD, Melbe K, Brandt N, Thiel E (2001) Clin Chem Lab Med 39:1267–1277
Monreal M, Costa J, Salva P (1996) Drugs Aging 8:171–182
Metz BK, White HD, Granger CB, Simes RJ, Armstrong PW, Hirsh J, Fuster V, MacAulay CM, Califf RM, Topol EJ (1998) J Am Coll Cardiol 31:1493–1498
Ocava LC, Singh M, Malhotra S, Rosenbaum DM (2006) Clin Geriatr Med 22:135–154
Olli S (1981) Anal Biochem 111:276–282
Rashid F, Sharma S, Bano B (2005) Protein J 24:283–292
Rijken DC, Groeneveld E, Barrett-Bergshoeff MM (1994) Thromb Haemost 72:906–911
Roberts MJ, Bentley MD, Harris JM (2002) Adv Drug Deliv Rev 54:459–476
Rudd MA, George D, Johnstone MT, Moore RT, Collins L, Rabbani LE, Loscalzo J (1992) Circ Res 70:829–834
Rudolph R, Lilie H (1996) FASEB J 10:49–56
Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton JW (1990) Science 249:277–280
Stam J (2005) N Engl J Med 352:1791–1798
Stern A, Kohnert U, Rudolph R, Fischer S, Martin U (1993) US Patent:5223256 Boehringer Mannheim GmbH
Smalling RW (1997) Eur Heart J 18:F11–F16
The International Study G (1990) Lancet 336:71–75
Tsujita K, Kaikita K, Soejima H, Sugiyama S, Ogawa H (2010) Nippon Rinsho 68:607–614
Yasuda T, Gold HK, Yaoita H, Leinbach RC, Guerrero JL, Jang IK, Holt R, Fallon JT, Collen D (1990) J Am Coll Cardiol 16:714–722
Acknowledgments
This study was supported by the Open Foundation of the State Key Laboratory of Biochemical Engineering (China Grant Number: 2005KT2-23, No. KF2008-7) and the Ministry of Education Doctor Foundation (Grant Number: 20040316005).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Ling Gao and Chun Zhang contributed equally to this work and should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Gao, L., Zhang, C., Li, L. et al. Construction, Expression and Refolding of a Bifunctional Fusion Protein Consisting of C-Terminal 12-Residue of Hirudin-PA and Reteplase. Protein J 31, 328–336 (2012). https://doi.org/10.1007/s10930-012-9407-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-012-9407-8